Pictet Asset Management
MDGL icon

Pictet Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Pictet Asset Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Buy
192,896
+5,656
+3% +$2.9M 0.1% 221
2026
Q1 		$97.9M Buy
187,240
+5,291
+3% +$2.53M 0.1% 217
2025
Q4 		$106M Sell
181,949
-9,847
-5% -$5.03M 0.1% 213
2025
Q3 		$87.7M Sell
191,796
-16,470
-8% -$6.14M 0.08% 234
2025
Q2 		$63M Buy
208,266
+1,223
+0.6% +$364K 0.06% 279
2025
Q1 		$68.5M Sell
207,043
-1,441
-0.7% -$473K 0.08% 256
2024
Q4 		$64.3M Buy
208,484
+57,886
+38% +$16.3M 0.07% 261
2024
Q3 		$32M Buy
150,598
+13,323
+10% +$3.41M 0.04% 378
2024
Q2 		$38.5M Sell
137,275
-46,888
-25% -$11.2M 0.04% 328
2024
Q1 		$48.4M Buy
184,163
+12,998
+8% +$3.06M 0.05% 314
2023
Q4 		$39.6M Buy
171,165
+59,740
+54% +$10.5M 0.04% 346
2023
Q3 		$16.3M Buy
+111,425
New +$21M 0.02% 513

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Pictet Asset Management's MDGL Position: Q2 2026 in Review

Pictet Asset Management increased its Madrigal Pharmaceuticals (MDGL) stake by 3% in Q2 2026, buying an estimated $2.9M and bringing the position to 192,896 shares worth $103M. The position accounts for 0.1% of the portfolio, ranked #221.

Pictet Asset Management first reported a position in MDGL in Q3 2023 and has held it in 12 quarters since. The position peaked at $106M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Pictet Asset Management held 192,896 shares of Madrigal Pharmaceuticals worth $103M as of Q2 2026.
  • Pictet Asset Management bought 5,656 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.9M.
  • Madrigal Pharmaceuticals made up 0.1% of Pictet Asset Management's portfolio in Q2 2026, its #221 holding.
  • Pictet Asset Management first reported a position in Madrigal Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Madrigal Pharmaceuticals position peaked at $106M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.